MTBC Declares Dividends on Non-Convertible Series A Cumulative Redeemable Perpetual Preferred Stock

SOMERSET, NJ--(Marketwired - May 15, 2017) - MTBC (NASDAQ: MTBC) (NASDAQ: MTBCP), a leading provider of proprietary cloud-based electronic health records, practice management and mHealth solutions, today announced that its Board of Directors has declared monthly cash dividends for its 11% Series A Cumulative Redeemable Perpetual Preferred Stock ("Series A Preferred Stock") for June, July and August 2017. This represents 21 consecutive months of dividends declared since the Series A Preferred Stock was initially sold in November 2015.

Holders of shares of the Series A Preferred Stock are entitled to receive cumulative cash dividends at the rate of 11% per annum of the $25.00 per share liquidation preference (equivalent to $2.75 per annum per share). Dividends on the Series A Preferred Stock are payable monthly on the 15^th day of each month; provided that if any dividend payment date is not a business day, then the dividend may be paid on the next succeeding business day. Dividends are payable to holders of record on the applicable record date, which shall be the last day of the calendar month, whether or not a business day.

MTBC's Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."

The following table shows the monthly dividends and associated record and payment dates:

		June 2017		July 2017		August 2017
Dividend per share		$0.22917		$0.22917		$0.22917
Ex-dividend date		June 28, 2017		July 27, 2017		Aug. 29, 2017
Record date		June 30, 2017		July 31, 2017		Aug. 31, 2017
Payment date		July 17, 2017		Aug. 15, 2017		Sept. 15, 2017

About MTBC

Medical Transcription Billing, Corp. is a healthcare information technology company that provides a fully integrated suite of proprietary web-based solutions, together with related business services, to healthcare providers throughout the United States. Our integrated Software-as-a-Service (or SaaS) platform helps our customers increase revenues, streamline workflows and make better business and clinical decisions, while reducing administrative burdens and operating costs. MTBC's common stock trades on the NASDAQ Capital Market under the ticker symbol "MTBC," and its Series A Preferred Stock trades on the NASDAQ Capital Market under the ticker symbol "MTBCP."

For additional information, please visit our website at www.MTBC.com.

Follow MTBC on TWITTER, LINKEDIN and FACEBOOK.

SOURCE MTBC

Disclaimer

This press release is for information purposes only, and does not constitute an offer to sell or solicitation of an offer to buy, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.